Gut and Liver 2009; 3(1): 14-19 https://doi.org/10.5009/gnl.2009.3.1.14 Immune Activation and Gut Microbes in Irritable Bowel Syndrome
Author Information
Khaldun Al-Khatib and Henry C. Lin
Gastroenterology Section, New Mexico VA Health Care System, Albuquerque, NM, and Department of Medicine, University of New Mexico, Albuquerque, NM, USA

Henry C. Lin
© The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. All rights reserved.

Abstract
Irritable bowel syndrome (IBS) is a highly prevalent disorder that is characterized by chronic abdominal pain and altered bowel habit. The diagnosis of IBS has traditionally been made by matching the complaints of the patient with established clinical criteria, since the underlying pathophysiology was not known. Various new findings have recently been reported in IBS patients that challenge our concept of IBS as a syndrome with no explanation. While the florid inflammation characteristic of inflammatory bowel disease is absent in IBS, changes suggesting immune activation are present in nearly all IBS patients. Is IBS an autoimmune disease, or is the immune activation responding to a trigger? In this review we present evidence that points to a state of immune activation in IBS and show data that suggest that small intestinal bacterial overgrowth triggers immune activation in IBS. (Gut and Liver 2009;3:14-19)
Keywords: Functional bowel disorders; Small intestinal bacterial overgrowth; Dysbiosis; Immune response
Abstract
Irritable bowel syndrome (IBS) is a highly prevalent disorder that is characterized by chronic abdominal pain and altered bowel habit. The diagnosis of IBS has traditionally been made by matching the complaints of the patient with established clinical criteria, since the underlying pathophysiology was not known. Various new findings have recently been reported in IBS patients that challenge our concept of IBS as a syndrome with no explanation. While the florid inflammation characteristic of inflammatory bowel disease is absent in IBS, changes suggesting immune activation are present in nearly all IBS patients. Is IBS an autoimmune disease, or is the immune activation responding to a trigger? In this review we present evidence that points to a state of immune activation in IBS and show data that suggest that small intestinal bacterial overgrowth triggers immune activation in IBS. (Gut and Liver 2009;3:14-19)
Keywords: Functional bowel disorders; Small intestinal bacterial overgrowth; Dysbiosis; Immune response
Search for
Services
Archives